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Glutamate is involved in excitotoxic mechanisms by interacting with different receptors.
Such interactions result in neuronal death associated with several neurodegenerative
disorders of the central nervous system (CNS). The aim of this work was to study the
time course of changes in the expression of GluR1 and GluR2 subunits of glutamate
amino-acid-3-hydroxy-5-methyl-isoxazol-4-propionic acid (AMPA) receptors in rat
hippocampus induced by NMDA intrahippocampal injection. Rats were submitted to
stereotaxic surgery for NMDA or saline (control) microinjection into dorsal hippocampus
and the parameters were evaluated 24 h, 1, 2, and 4 weeks after injection. The
extension and efficacy of the NMDA-induced injury were evaluated by Morris water
maze (MWM) behavioral test and Nissl staining. The expression of GluR1 and GluR2
receptors, glial fibrillary acidic protein (GFAP), and neuronal marker (NeuN) was analyzed
by immunohistochemistry. It was observed the impairment of learning and memory
functions, loss of neuronal cells, and glial proliferation in CA1 area of NMDA compared
with control groups, confirming the injury efficacy. In addition, NMDA injection induced
distinct changes in GluR1 and GluR2 expression over the time. In conclusion, such
changes may be related to the complex mechanism triggered in response to NMDA
injection resulting in a local injury and in the activation of neuronal plasticity.
Keywords: AMPA receptors, hippocampus, neurodegenerative disorders, NMDA, excitotoxicity,
immunohistochemistry, Morris water maze
INTRODUCTION
Glutamate is the main and most abundant excitatory neurotransmitter in the Central Nervous
System (CNS) with key role in several physiological functions. However, excessive concentrations
of glutamate result in overstimulation of the ionotropic receptors leading to increased Ca2+ influx
into the neurons. High Ca2+ levels trigger an intracellular mechanism known as excitotoxicity
that induces neuronal death. This cascade of events has been reported in most neurodegenerative
disorders of the CNS (Ozawa et al., 1998; Kim and Frank, 2009).
The ionotropic glutamate receptors (iGluRs) are a complex of transmembrane proteins
assemblies that reflect the receptor permeability to the influx of ions (Hollmann and Heinemann,
1994; Rosa, 2006). These receptors are classified according to their agonists N-methyl-D-aspartate
(NMDA), amino-acid-3-hydroxy-5-methyl-isoxazol-4-propionic acid (AMPA), and kainate (KA).
Specifically, the AMPA receptors are formed by the assembly of four different protein subunits,
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known as GluR1-4, derived from a single gene. GluR1, 3,
and 4 have different permeabilities to Ca2+ while GluR2
is totally impermeable. The presence of at least one GluR2
in the receptor composition is enough to reduce the Ca2+
permeability (Meldrum, 2000). In addition, the alternative
splicing of genes encoding the subunits originates two isoforms of
each, flip and flop, with distinct physical and chemical properties.
The distribution of these subunits and isoforms is different
considering the brain region and the stage of development
(Sommer et al., 1990; Hollmann and Heinemann, 1994; Pires
et al., 2000).
Some evidences have indicated the involvement of glutamate
by interacting with different receptors in the mechanisms
underlying the CNS development, including cell proliferation
and migration, morphological changes of neurites, neuronal
differentiation, and neurogenesis (Pires et al., 2006; Ritter, 2011).
Considering the AMPA receptors, studies have demonstrated
that they are differentially regulated through the expression of
specific subunits resulting in distinct Ca2+ influx that affects
neuronal functions such as synaptic plasticity and neuronal
survival or excitotoxicity (Pellegrini-Giampietro, 2003; Pires
et al., 2006). The ion exchange through neuronal membrane
induces activation of voltage-dependent NMDA receptors in
the membrane and cellular changes that trigger intracellular
responses such as activation of second messengers (Malinow and
Malenka, 2002; Sheng and Lee, 2003).
Overstimulation of NMDA receptors also induces marked
increase of Ca2+ influx as all subunits of these receptors
are permeable to this ion. Several studies have shown
the involvement of Ca2+ influx through these receptors in
mechanisms underlying short- or long-term alterations in the
CNS such as long-term potentiation (LTP) that is essential for
memory formation and a cellular model of synaptic plasticity
(Prybylowski and Wenthold, 2004). In addition to NMDA,
the presence of GluR1 in AMPA receptors contributes to
synaptic potentiation during LTP (Rumpel et al., 2005) as well
as receptors deficient in GluR2 contribute to enhanced LTP,
suggesting an important regulatory mechanism associated with
the composition of AMPA receptors (Jia et al., 1996).
NMDA intrahippocampal injection induces substantial loss of
hippocampal tissue and gliosis (Bardgett et al., 2003) and has
been largely used as an experimental model of neurodegenerative
processes such as ischemia, Alzheimer’s and Parkinson’s disease,
multiple and amyotrophic lateral sclerosis, epilepsy, and aging
(Bowie, 2008). It has been demonstrated that this injury induces
impairment of spatial memory in rats (Bardgett et al., 2003,
2006) as mammalian hippocampus is involved in mechanisms
underlying the acquisition of new information, learning, and
memory (Bertoglio et al., 2006).
Although the involvement of AMPA receptors in
neurodegenerative processes is already known (Ozawa et al.,
1998), changes in the expression of specific subunits after injury
have not been demonstrated in a time course way. Thus, the aim
of this study was to analyze by immunohistochemistry GluR1
and GluR2 expression in hippocampus (CA1, CA3, and hilus of
dentate gyrus at different time points after local microinjection
of NMDA in rats. The lesion efficacy was evaluated by behavioral
test using the Morris water maze (MWM), one of the most
widely spatial memory test used in rodents (Talpos et al.,
2008). The histological alterations related to the loss of neurons




Forty eight male Wistar rats (220–250 g) were allocated in pairs
in a temperature-controlled room (23 ± 1◦C) and a 12:12-h
light:dark cycle (lights on at 7 a.m.) with food and water ad
libitum. Animal handling and all experiments were performed
according to the Brazilian Society of Neuroscience and Behavior
guidelines for care and use of laboratory animals, and all
efforts were made to minimize animal suffering. This study
was approved by the Ethics Committee for Care and Use of
Laboratory Animals of the University of Sao Paulo, campus
Ribeirao Preto (CEUA # 10.1.619.53.3).
Surgery and NMDA Intrahippocampal
Injection
Eight experimental groups were used (n = 6/each): Control
and NMDA (analyzed 24 h, 1, 2, and 4 weeks after either
saline or NMDA injection, respectively). Fifteen minutes before
the surgical procedure the animals received atropine sulfate
(0.1mL, 0.5 mg/mL) and then were anesthetized with ketamine
hydrochloride (60mg/kg; Agener Union) plus xylazine (8mg/kg;
Cali). They were fixed in a stereotaxic device (Stoelting-Standard)
and received a local injection of lidocaine (2%, S.S. White
100). After 30 s an incision was made on the top of the
head in order to expose the skull. Based on the bregma
point (the junction point of the sagittal and coronal sutures
of the skull) the following coordinates were used to reach
the dorsal hippocampus, according to Paxinos and Watson
(1986): AP: −3.8, ML: ± 1.4, DV: −2.0. Then, the animals
received a bilateral injection of NMDA (0.2mL, 12 mg/mL,
Sigma) and intramuscular injections of diazepam (1mg/kg,
Cristalia) to prevent the occurrence of seizures, and antibiotics
(penicillin, streptomycin, and dihydrostreptomycin) (50mg/kg,
Fort Dodge). The incisions were sutured and the animals were
left undisturbed until behavioral test or histological procedures.
Behavioral Test (MWM)
Two and 4 weeks after either NMDA or saline injection, the
animals (n = 6/group) were tested in the MWM (Morris, 1984),
using a circular polyethylene pool (1.40 cm diameter and 50 cm
deep) filled with water (23◦C) containing 2 L of milk to prevent
the animals of seeing the platform. A white platform (9 cm
diameter) was allocated on the southeast quadrant and visual cues
(geometric figures: square, triangle, circle, and star) were placed
on the walls of the room. The experimental protocol consisted of
24 training sessions (six sessions/day for four consecutive days)
and one test session (probe trial, day 5). Each session lasted
until either the animal find the platform or the cutting time of
90 s, when the animal was removed. In this case, the animal was
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manually driven to the platform, kept on that for 30 s and again
placed in water. In the training sessions the escape latencies to
find the platform were recorded. At day 5, the platform was
removed to perform the probe trial that consisted of recording
the swimming time in each quadrant during 60 s in the maze.
The time spent in the quadrant where the platform used to be
was taken as an index of memory. The test evaluated the ability
of acquisition (training sessions with the platform) and retention
(test sessionwithout the platform) of the spatial information. One
day and 1 week groups were not included in this behavioral test
as the rats must be recovered from the surgery for at least 1 week.
Thus, they can not be submitted to the test considering 1 week of
training needed (1–4 days) before the probe trial (day 5).
Histological Procedures
After the behavioral test, all animals were anesthetized (urethane,
25%, Sigma) and killed by perfusion with intracardiac infusion of
0.1M phosphate buffered saline (PBS), pH 7.4, followed by 4%
paraformaldehyde in PBS. The brains were promptly removed
and soaked in the same fixative solution for 2 h (4◦C) and then
cryoprotected by soaking in 30% sucrose in PBS for 48–72 h
(4◦C). Brains were frozen in isopentane (Sigma) cooled in dry
ice (−40◦C) and stored at −70◦C until sectioning. Twenty-
four hours before sectioning the brains were transferred to a
−20◦C freezer. Selection of anatomical levels for sectioning
was conducted based on illustrations from Paxinos and Watson
(1986). Transverse sections (30µm) containing hippocampus
were obtained in a cryostat (−20◦C, Leica) and processed for
Nissl staining (3 sections/animal from control and NMDA 2 and
4 weeks) or immunohistochemistry (3 sections/animal).
Immunohistochemistry
For immunohistochemistry revealed with chromogen 3,3-
diaminobenzidine (DAB. Sigma), hippocampal sections
of all groups were successively washed and incubated at
room temperature with the anti-GluR1 (1:500, Chemicon)
or anti-GluR2 (1:400, Millipore) primary antibodies. After
18 h, they were washed in PBS and sequentially incubated
with a biotinylated secondary antibody (1:250, Dako) for
90min. The sections were then processed by the avidin-biotin
immunoperoxidase method (Vectastain ABC kit, Vector
Laboratory). GluR1 or GluR2 immunoreactivity was revealed
by the addition of DAB and hydrogen peroxide (Merck). The
sections were mounted on gelatin-coated slides, dehydrated,
and cover slipped for microscopic analysis. The sections were
observed and the subfields of the hippocampus (CA1, CA3, and
hilus) were captured using a light microscope coupled with a
digital camera (DFC300 FX, Leica) for further quantification
using the image analysis software QWin Plus (Leica). GluR1-
and GluR2-positive neurons were visualized as brown in color.
Counting of GluR1- and GluR2-immunopositive cells (IC) was
performed in the entire field of view at 200x magnification (i.e.,
10x eyepiece and 20x plan objective), corresponding to a fixed
area of 566 × 424µm (0.24mm2) for each hippocampal region.
Images of each region in the magnification used for quantifying
the positive cells are showed in the Supplementary Material
(GluR1, Figure S1 and GluR2, Figure S2). One whole field per
region was counted in three sections from each animal, bilaterally
(6 values/region/rat) and the values used to calculate the average
expressions. The results were expressed as the number of GluR1-
and GluR2-IC/0.1mm2. As the NMDA injection was made
into the CA1, the IC of this region were counted in the lesion
adjacent area. Due to the high density of GluR1- and GluR2-IC
in the layers of neurons in CA1 and CA3, the expression of both
subunits in these areas was also measured by densitometry. The
images were captured and transformed in black and white and
the optical density (OD) was measured in gray scale using the
Image J software. The analyzed areas were measured on right
and left hemispheres in all three sections of each animal and the
readings used to calculate the average expression.
For immunofluorescence, tissue sections of the 2 weeks
control and 1 and 4 weeks NMDA groups (n = 2/each)
were used. Eighteen hours before the experiment, the brain
tissues were moved from anti-freeze solution to phosphate buffer
(PB) 0.1M with Triton X-100 0.15%. Tissue sections were
successively washed and incubated at room temperature with
primary antibodies mouse anti-NeuN (1:1000, Millipore) and
mouse anti-GFAP (1:1000, Sigma) to detect neurons and glial
cells, respectively. After 60min all sections were washed in PB
0.1M and sequentially incubated with the secondary antibodies
(Alexa Fluor 594-red or Alexa Fluor 488-green). After 50min,
all sections were washed in PB 0.1M and incubated with DAPI
for 5min to label cell nuclei. The sections were washed again
in PB 0.1M and deionized water and mounted on non-gelatin-
coated slides with anti-fade and cover slipped for analysis using
fluorescence microscope outfitted with an AxiocamMRm digital
camera (Carl Zeiss).
Statistical Analysis
The statistical analyses were preformed using Graph Prism
software (version 4.0, GraphPad Software). The data fromMWM
test were compared by repeated measures either two-way or
one-way ANOVA followed by Bonferroni test. For Nissl and
imunnohistochemistry experiments, the data were compared
by one-way ANOVA followed by Newman–Keuls test. The
significance level was set at p ≤ 0.05.
RESULTS
Behavioral Test (MWM)
There were significant differences in the learning (Figure 1A)
and memory (Figure 1B) functions between control and NMDA
injected groups. The escape latency to find the platform was
progressively reduced from day 1 to day 4 of training for all
groups [F(3, 60) = 2.265; p < 0.0001; Figure 1A]. At day 1,
animals tested 2 weeks after NMDA injection showed an escape
latency higher than both controls and animals tested 4 weeks after
NMDA injection [F(3, 20) = 14.14; p < 0.0001]. However, no
significant difference was observed between NMDA tested at 4
weeks and control groups. At day 2, no difference in the escape
latency was observed between all groups. In contrast, at day 3
the NMDA groups tested at 2 and 4 weeks after injection showed
an escape latency 130 and 76% higher than controls, respectively
[F(3, 20) = 22.30; p < 0.0001]. Similarly, at day 4, the NMDA
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FIGURE 1 | Effect of intrahippocampal NMDA in MWM acquisition task
2 and 4 weeks after injection. (A) Escape latency to find the platform during
the four training sessions. (B) Time spent in the target quadrant during the
probe trial (without the platform). Data represent mean ± SEM
(n = 6/group). *p < 0.01 (Repeated measures two-way (A) or one-way (B)
ANOVA followed by Bonferroni test).
groups showed an escape latency 198 and 177% higher than
controls [F(3, 20) = 11.87; p < 0.01]. In the probe trial carried
out at day 5, both NMDA injected groups spent 40% less time
swimming in the target quadrant than controls [F(3, 20) = 25.55;
p < 0.0001; Figure 1B]. No difference was detected between both
NMDA injected groups [F(3, 20) = 1.172; p = 0.978].
Hippocampus Injury Induced by NMDA
Injection
At lower magnification, it was possible to observe the whole
hippocampus and to identify its specific areas, CA1, CA2, CA3,
and hilus, in control and NMDA groups 2 weeks after injection
(Figure 2A). It was noticed the loss of neurons in the CA1 region
of the NMDA injected compared with control group (Figure 2A,
bounded areas and higher magnification) indicating the lesion
effectiveness. A higher amount of glial cells and a reduction in
neuronal layer thickness was observed in NMDA groups, 2 and 4
weeks after injection, compared with control group 2 weeks after
injection (Figure 2B). A significant neuronal loss was observed
in CA1 and CA3 areas of the NMDA groups, 2 and 4 weeks after
FIGURE 2 | (A) Dorsal hippocampus of the control and NMDA groups 2
weeks after injection. Lower (top) and higher magnification of the bounded
areas (bottom). Plates used for neuron quantification (right) showing the injured
area (hachured) (modified from Paxinos and Watson, 1986). (B) CA1, CA3,
and hilus of the control, after 2 weeks, and NMDA after 2 and 4 weeks. (C)
Number of neurons in CA1, CA3, and hilus of the control, after 2 weeks, and
NMDA after 2 and 4 weeks. Data represent mean ± SEM of the number of
cells quantified bilaterally in three sections/rat (n = 6/group). Nissl
staining. ***p < 0.001 (one-way ANOVA followed by Newman–Keuls test).
injection, compared with control group 2 weeks after injection
(Figure 2C). The reduction was 50% after 2 weeks and 31%
after 4 weeks [F(2, 17) = 111.2; p < 0.0001] in CA1 and 24%
after 2 weeks and 27% after 4 weeks in CA3 [F(2, 17) = 54.96;
p < 0.0001]. In the hilus, no significant difference was observed
[F(2, 17) = 1.393; p = 0.279].
GluR1 Expression in Hippocampus
GluR1-immunopositive cells (IC) were observed in all
hippocampal areas of control and NMDA groups at all
evaluated time points (Figure 3) The expression of GluR1 was
concentrated in the neuron layers of CA1, CA3, and hilus
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FIGURE 3 | Immunohistochemistry for GluR1 in CA1 (A), CA3 (B), and hilus (C) of the control and NMDA groups evaluated at 24h, 1, 2, and 4 weeks
after intrahippocampal injection. Cells labeled with the chromogen 3,3-diaminobenzidine (DAB).
as well as in sparsely distributed cells throughout these areas
(Figure 3). Specifically in CA1 area, the population of GluR1-IC
in the control group remains as an organized layer over the
evaluated period (Figure 3A). In the NMDA groups, GluR1-IC
were observed both in the layer as well as randomly distributed
around it. Additionally, the increased thickness of the cell layer
detected in NMDA groups suggests a disruption in the region
adjacent to the injury. In CA3 area, a higher number of GluR1-IC
scattered around the dense layer of GluR1-IC was observed in
NMDA compared with control groups at all evaluated time
points (Figure 3B). Similarly, a higher density of GluR1-IC was
observed in the hilus of the NMDA groups (Figure 3C).
The quantitative analysis showed differences in GluR1
expression between control and NMDA groups regarding
hippocampal area and time after injection (Figure 4). In CA1,
the number of GluR1-IC increased in NMDA compared with
control groups at 1 (33%), 2 (20%), and 4 (35%) weeks after
injection [F(9, 53) = 10.40; p < 0.0001] but did not change at
24 h (Figure 4A). The optical density exhibited the same pattern
of GluR1-IC increasing in CA1 area in NMDA compared with
control groups at 1 (34%), 2 (43%), and 4 (51%) weeks after
injection [F(9, 48) = 12.75; p < 0.001] without changing at 24 h
(Figure 4B). In CA3 area, the number of GluR1-IC increased in
NMDA compared with control groups at 2 (22%) and 4 (21%)
weeks after injection [F(9, 53) = 3.726; p < 0.01] but did
not change at 24 h and 1 week (Figure 4C). The optical density
exhibited the same pattern of GluR1-IC increasing in CA3 area
in NMDA compared with control groups at 2 (37%) and 4 (37%)
weeks after injection [F(9, 49) = 6.640; p < 0.001] without
changing at 24 h and 1 week (Figure 4D).
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FIGURE 4 | Number of GluR1-immunopositive cells (A,C,E) and optical density (B,D) in CA1, CA3, and hilus of the control and NMDA groups evaluated
at 24h, 1, 2, and 4 weeks after intrahippocampal injection. Data represent mean ± SEM of the number of cells and optical density quantified bilaterally in three
sections/rat (n = 6/group). *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA followed by Newman–Keuls test).
In the hilus, the number of GluR1-IC increased in NMDA
compared with control groups at 24 h (41%), 1 (190%), and 2
(90%) weeks after injection [F(9, 53) = 27.15; p < 0.0001] but did
not change at 4 weeks (Figure 4E). The optical density was not
measured in the hilus as the GluR1-IC were spread preventing
the counting of individual cells. In addition, the pattern of cell
distribution could lead to optical density values with considerable
gray levels from the background area. No differences in GluR1-
IC between the control groups either submitted or not to MWM
behavioral test were observed at 2 and 4 weeks after injection
in all evaluated areas (Figures 4A–E). Omission of the primary
antibody anti-GluR1 resulted in complete loss of signal (data not
shown).
GluR2 Expression in Hippocampus
Similarly to GluR1, GluR2 expression was observed in all
hippocampal areas of control and NMDA groups at all evaluated
time points (Figure 5). However, GluR2-IC exhibited a different
pattern of localization compared with GluR1. They were
concentrated in cell layers and not sparsely distributed, except
in CA3 where few GluR2-IC were noticed around the cell
layer (Figure 5). In CA1, it was observed a reduction of the
GluR2-IC layer thickness in NMDA compared with control
groups at all evaluated time points (Figure 5A). In CA3, GluR2-
IC was distributed in a very similar way in control and
NMDA groups at all evaluated time points (Figure 5B). An
increase of GluR2-IC was observed in the hilus of NMDA
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FIGURE 5 | Immunohistochemistry for GluR2 in CA1 (A), CA3 (B), and hilus (C) of the control and NMDA groups evaluated at 24h, 1, 2, and 4 weeks
after intrahippocampal injection. Cells labeled with the chromogen 3,3-diaminobenzidine (DAB).
compared with control groups at all evaluated time points
(Figure 5C).
The quantitative analysis showed differences in GluR2
expression between control and NMDA groups in CA1 and hilus
over the time after injection, but not in CA3 (Figure 6). In
CA1, the number of GluR2-IC decreased in NMDA compared
with control groups at 24 h (60%), 1 (53%), 2 (75%), and 4
(78%) weeks after injection [F(9, 56) = 146.9; p < 0.0001]
(Figure 6A). The optical density exhibited a similar pattern of
GluR2-IC decreasing in CA1 area in NMDA compared with
control groups at 24 h (44%), 1 (59%), 2 (65%), and 4 (69%)
weeks after injection [F(9, 49) = 23.50; p < 0.001; Figure 6B].
In CA3, it was not observed differences between NMDA and
control groups regarding GluR2-IC amount as evaluated by
both cell counting (Figure 6C) [F(9, 53) = 0.3251; p = 0.96]
and optical density (Figure 6D) [F(9, 49) = 0.8004; p =
0.6181]. In contrast to the CA1, in the hilus the number of
GluR2-IC increased in NMDA compared with control groups
at 24 h (28%), 1 (65%), and 2 (25%) weeks after injection
[F(9, 53) = 18.18; p < 0.0001] but did not change at 4 weeks
(Figure 6E). The optical density was not measured in the hilus
as the GluR2-IC displayed the same pattern of distribution as
described for GluR1 in this area. No differences in GluR2-IC
between the control groups either submitted or not to MWM
behavioral test were observed at 2 and 4 weeks after injection
in all evaluated areas (Figures 6A–E). Omission of the primary
antibody anti-GluR2 resulted in complete loss of signal (data not
shown).
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FIGURE 6 | Number of GluR2-immunopositive cells (A,C,E) and optical density (B,D) in CA1, CA3, and hilus of the control and NMDA groups evaluated
at 24h, 1, 2, and 4 weeks after intrahippocampal injection. Data represent mean ± SEM of the number of cells and optical density quantified bilaterally in three
sections/rat (n = 6/group). *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA followed by Newman–Keuls test).
GFAP and NeuN Expression in
Hippocampus
The GFAP labeling (green) was observed in control and NMDA
groups in the adjacent area of injection 1 and 4 weeks after
injection and it was associated with nuclei labeled with DAPI
(blue; Figure 7A). As expected, the expression of GFAP increased
in NMDA compared with control group 1 week after injection
and reduced 4 weeks after injection to similar levels of control
group. The NeuN (red) was also detected in all evaluated groups
associated with cell nuclei (Figure 7B). In contrast with GFAP,
the expression of NeuNwas slightly reduced inNMDA compared
with control group 1 week after injection and increased 4 weeks
after injection reaching similar levels of control group. The
expression of GFAP in the NMDA injected area 1 week after
injection indicates the intense and disorganized glial proliferation
induced by injury (Figure 8A). In addition, the absence of NeuN
labeled cells indicates that NMDA injection induced nearly 100%
of neuronal death in this area. As in these areas the nuclei may
not be associated with neurons, they probably refer to glial cells.
Four weeks after NMDA injection, GFAP expression was reduced
(Figure 8B) compared with 1 week. In contrast with 1 week,
NeuN expression was observed in this area 4 weeks after NMDA
injection. The NeuN expression was mainly associated with the
organized layer of nuclei in the image center. Panoramic views of
the GFAP and NeuN labeling in the hippocampus of control rats
are showed in the Supplementary Material (Figure S3).
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FIGURE 7 | Immunofluorescent labeling for glial cells (A, GFAP–green)
and neuronal cells (B, NeuN–red) in CA1 (adjacent area of injection) of
the control and NMDA groups 1 and 4 weeks after injection. Nuclei
labeled with DAPI (blue).
DISCUSSION
The present study showed the time course of changes in the
expression of GluR1 and GluR2 in hippocampus induced by a
local injection of NMDA. Briefly, our results demonstrated that
NMDA induced distinct alterations in the expression of each
subunit depending on the specific hippocampus subfields and the
time after injection.
The efficacy of the hippocampal lesion was analyzed in
terms of function by the MWM behavioral test for learning
and memory, and histologically by Nissl staining. The findings
from MWM suggest that NMDA induced a partial deficit in the
hippocampal functions as we observed impairment in memory
evocation in all periods after injection, but not a complete deficit
of learning. Although the animals injected with NMDA showed
higher escape latency than controls to reach the platform when
tested 2 and 4 weeks after injection, they learned the task, as the
latencies progressively decreased over the four training days. In
addition, in the probe trial without platform, even the NMDA
groups spent considerable less time than controls in the target
FIGURE 8 | Immunofluorescent labeling for glial cells (GFAP–green)
and neuronal cells (NeuN–red) in CA1 (injected area) 1 week (A) and 4
weeks (B) after injection. Nuclei labeled with DAPI (blue).
quadrant, staying there 30% of the total time. It has been reported
that learning and memory functions essentially depend of the
hippocampus integrity (Broadbent et al., 2004). These authors
have shown that spatial memory is not completely disrupted by
lesions affecting up to 40–60% of the total hippocampus and
that lesions from 30 to 50% induce learning disabilities, but
the animals do not stop learning. Furthermore, the application
of colchicine into the rat dentate gyrus interferes with the
spatial memory when tested in the MWM, radial, and T maze,
while lesions only in CA1 did not tend to produce deficits
(Costa et al., 2005). Therefore, the DG integrity is considered
essential for spatial orientation. Both studies support our results
as in our model of injury, although the histological findings
from Nissl staining showed evident cell loss in CA1 and CA3,
it was not detected in hilus, suggesting its integrity. These
findings may explain the partial learning of animals injected
with NMDA. Thus, the histological and functional efficacies of
the hippocampal injury induced by NMDA were demonstrated
in this study. This experimental design can also be used as a
model of excitotoxic injury in further investigations to improve
the understanding of neurodegenerative processes and the events
arising from them.
As previously mentioned, it is well-known that different
subtypes of glutamate receptors are largely distributed in
CNS (Hollmann and Heinemann, 1994; Ozawa et al., 1998).
Regarding the AMPA receptors, the distribution of distinct
Frontiers in Neuroscience | www.frontiersin.org 9 February 2016 | Volume 10 | Article 32
Fachim et al. Intrahippocampal NMDA Affects AMPA Expression
subunits is different among brain areas (Eastwood et al., 1994;
García-Ladona et al., 1994) and neuronal types (Jonas et al.,
1994). In this study, the expression of GluR1 and GluR2 was
not uniform in hippocampus, in agreement with the classic
distribution of AMPA receptors reported for the rat brain (Ozawa
et al., 1998; Danbolt, 2001). In addition, it is known that the
assembly of different subunits results in AMPA channels with
different Ca2+ permeability (Mosbacher et al., 1994). Thus,
the GluR1:GluR2 ratio changes the Ca2+ influx in specific cell
populations and brain conditions such as stage of development,
physiological functions, pathological processes, toxicicity, and
neurodegeneration and mechanisms of plasticity (Hume et al.,
1991; Pellegrini-Giampietro, 2003).
In this work, the hippocampal injury induced by NMDA
resulted in a time course of distinct changes in GluR1 and GluR2
expression. Considering CA1, the injected hippocampal subfield,
the GluR1 expression in cells adjacent to the lesion was increased,
while the expression of GluR2 was decreased during the whole
time course evaluated. These alterations result in an increase in
GluR1:GluR2 ratio with consequent excessive Ca2+ influx in this
subfield that may promote neurotoxic processes. Our histological
results showed death cells in CA1 1 week but not 24 h after
NMDA injection (results from 24 h are not shown), consistent
with the increased expression of GluR1, the AMPA subunit highly
permeable to Ca2+, at 1 week but not at 24 h. It is probable that
the mechanisms of neurotoxicity had been immediately triggered
after NMDA injection, but they did not result in changes in the
expression of GluR1 detected by our method. However, GluR2
expression was highly decreased 24 h after NMDA injection,
suggesting that a reduced GluR2 role in regulating Ca2+ influx
through AMPA receptors is part of the mechanisms of toxicity
firstly triggered by NMDA that results in neuronal death
later.
Considering the time course evaluated in this study, the
changes in the expression of both subunits were observed up
to 4 weeks after NMDA injection. While NMDA immediately
elicits toxicity, the resulting neurodegeneration triggers plasticity
mechanisms in order to keep the functional integrity of the
brain. Glutamate, through distinct receptors, has been shown
to underlie the brain excitability in response to high influx
of Ca2+ that is crucial for cell proliferation, neurogenesis and
synaptogenesis, among other mechanisms of neuronal plasticity
and regeneration (Molnar et al., 2002; Rakhade et al., 2008).
The involvement of AMPA receptors in mediating fast synaptic
transmission has been demonstrated to contribute to synaptic
plasticity that underlies learning and memory (Du et al., 2004;
Fei et al., 2006; Harrison et al., 2007; Zhang et al., 2007).
Malinow (2003) showed that the presence of GluR1 subunit is
linked to the LTP formation that is essential for strengthening
and effectiveness of synapses in both during the postnatal
development and the recovery after brain injury. Additionally,
it was demonstrated that GluR1 subunit plays a critical role
in mediating synaptic plasticity and cognition (Malinow and
Malenka, 2002; Suk et al., 2004). Based in all these evidences, our
results suggest that the changes in GluR1 and GluR2 expression
until 4 weeks after NMDA injection may be involved in the
mechanisms of plasticity triggered by the lesion.
The results from immunofluorescence showed complete
absence of neurons labeled with NeuN in the lesioned area of
CA1 at 1 week after NMDA injection, in agreement with our
histological results using Nissl staining. We also observed intense
labeling for GFAP in this area at the same time point evidencing
the typical gliosis that occurs in response to neuronal insults.
Agreeing with this, the upregulation of GFAP in astrocytes has
been reported to be a spontaneous response to brain injury that
contributes to both reactive gliosis and formation of the glial scarf
(Sofroniew, 2009). In contrast, at 4 weeks after NMDA injection
we observed few NeuN-lebeled neurons in the lesioned CA1
suggesting a possible initial reorganization of the area. Based on
our data, it is not possible to confirm that these NeuN-positive
cells are new neurons since a specific label for this kind of cells
such as bromodeoxyuridine (BrdU) was not used. However, the
absence of NeuN-positive cells 1 week after lesion suggests that
the neurons in the lesioned area after 4 weeks were originated
from migration of the DG subgranular zone. This hypothesis is
supported by recent findings demonstrating an increase in glial
cells and BrdU-positive granular neurons in the hippocampus
of mouse after cerebral trauma (Gao and Chen, 2013). These
authors suggest that the trauma triggers innate mechanisms
of plasticity and repair through the proliferation of progenitor
cells. In this context, previous experiments demonstrated that in
vivo astrocytes from human lateral ventricle showed a behavior
similar to cultured neural progenitor cells (Sanai et al., 2004).
In a different context, Ming and Song (2005) reported that
specific kinds of injuries may activate neurogenesis through
endogenous neural progenitor cells in areas where the adult
neurogenesis is limited. However, the authors do not known
if these new neurons are functional. So, these findings also
contribute to explain our results from the memory test on
the MWM 4 weeks after NMDA injection when the animals
remained with cognitive deficit.
It has been reported an increase of neurogenesis in
hippocampus of animals submitted to MWM or physical
exercises related to learning (Epp et al., 2011; Inostroza et al.,
2011; Chow et al., 2012). In addition, Huang et al. (2010)
reported an increase in the expression of GluR1 in CA1 of
rats with impaired fetal growth after being exposed to MWM.
Together, these findings show that the exposure to specific
physical conditionsmay improve learning andmemory functions
and that GluR1 is involved in these mechanisms (Huang et al.,
2010). In agreement with this, Okada et al. (2003) showed that
an increase of Ca2+ influx in CA1 through AMPA receptors
is associated with learning. In this context, the present work
shows that only the exposition to MWM was not enough to
activate the subunits GluR1 and GluR2, as we did not observed
significant differences in the expression of both subunits when
the animals treated with saline and exposed to MWM were
compared to the animals also treated with saline but not exposed
to MWM. Such finding suggests that only the exposition to
behavioral test do not trigger mechanisms of plasticity and repair.
However, considering that the mechanisms of plasticity were
triggered by an excitotoxic stimulus, the MWM test becomes
important as it involves physical exercise and learning and
memory processes. Altogether, changes in the expression of
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GluR1, GluR2, GFAP, and NeuN in the lesioned CA1 over 4
weeks after NMDA injection suggest that AMPA subunits are
involved in distinct mechanisms activated in a time-dependent
way, i.e.,: excitotoxicity that lead to cell death at the initial periods
after injury and plasticity events at the later evaluated time
point.
The time course of the changes induced by NMDA injection
in the expression of GluR1 and GluR2 in CA3 and hilus exhibited
different patterns. While in CA3 we observed an increase in
GluR1 without alteration in GluR2, in the hilus both subunits
were increased at all evaluated time points. Considering that the
subgranular zone of the dentate gyrus is rich in stem cells and
the subfields of the dentate gyrus have distinct cells types, our
findings may be related to either the appearance of new cells or
changes in the assembly of AMPA receptor subunits, agreeing
with the plasticity mechanisms triggered in response to injury.
Zhang et al. (2011) showed that the dentate gyrus acts as a filter
to block the exacerbation of signal from cortex to CA3 and then
to CA1, suggesting that any neuronal lost in dentate gyrus is able
to disturb the normal balance between excitation and inhibition
in this area.
It has been demonstrated that the electrical stimuli in
dentate gyrus are controlled by different types of GABAergic
interneurons that play a crucial role in the control of
hippocampus-cortex interactions and in maintaining the dentate
gyrus integrity (Zhang et al., 2011). Thus, the neuronal loss in the
hilus could induce a decrease in the inhibition by GABA resulting
in an increase of the dentate gyrus excitability. In addition, these
interneurons express calcium-binding proteins that have a role
of buffering the calcium excess (do Nascimento et al., 2012).
These findings contribute to explain the differential susceptibility
of each area to degeneration, as the neurons with few or none
calcium-binding proteins are more sensitive to death triggered
by excitotoxicity. They also corroborate the low susceptibility
of dentate gyrus neurons to death by excitotoxicity observed in
this study as CA1, but not dentate gyrus, was the site of NMDA
injection in our model of injury. Furthermore, the expression
of AMPA subunits observed in the hilus 1 and 2 weeks after
injury exhibited an increasedGluR1:GluR2 ratio, indicatingmore
vulnerability to death at this time points. In contrast, similar
increase in the expression of both subunits was observed 4
weeks after injury, resulting in lack of change in GluR1:GluR2
ratio suggesting that this specific assembly of subunits in the
receptor underlies the mechanisms of maintenance of the dentate
gyrus integrity after the excitotoxic stimulus. Conversely, in CA3
an increase only in GluR1 was observed 2 and 4 weeks after
injury, increasing GluR1:GluR2 ratio and contributing to the
vulnerability of this subfield to neurotoxic mechanisms. These
findings are similar to those reported by Jiang et al. (2008) after
induction of seizures in hippocampal cells cultures.
The brain mechanisms underlying the injury, plasticity
or repair triggered in response to NMDA intrahippocampal
injection are extremely complex and involve other cerebral areas
and neurotransmitters than hippocampus and glutamate (Bowie,
2008). This study demonstrated a distinct balance between GluR1
and GluR2 along the time course evaluated. In addition, both
subunits have two isoforms, flip and flop, with distinctive kinetic
properties that may influence Ca2+ influx depending on the
assembly of subunits in the receptor, as the flip isoform allows
greater influx of this ion (Sommer et al., 1990).
Considering the glutamatergic loop in the hippocampus
(Bloodgood and Sabatini, 2008) that involves synaptic
connections among hilus, CA3, and CA1 together with all
evidence described above, it is possible that the distinct changes
in GluR1 and GluR2 expressions are related to the complex
glutamatergic mechanisms triggered in hippocampus in
response to NMDA injection resulting in a local injury and in
the activation of neuronal plasticity.
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